SLMAP Inhibitors
SLMAP (sarcolemmal membrane-associated protein) inhibitors belong to a specific chemical class of compounds that interact with and modulate the activity of SLMAP, a protein found in the sarcolemma, or the cell membrane, of muscle cells. SLMAP plays a crucial role in cellular processes and signaling pathways involved in muscle function. By inhibiting SLMAP, these compounds may affect various cellular functions, though the specific mechanisms are beyond the scope of this description. Researchers have been studying SLMAP inhibitors to better understand their interactions with the protein and the potential implications on cellular physiology.
These inhibitors have drawn interest for their potential applications in research and discovery, as they can be valuable tools to investigate the intricate workings of muscle cells and related pathways. The chemical design and development of SLMAP inhibitors are areas of active scientific investigation, with researchers aiming to optimize their specificity and potency. Ongoing studies continue to explore the diverse effects of these inhibitors on muscle cell biology, which could contribute to a deeper understanding of cellular processes and may hold promise for future scientific advancements.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a widely studied SLAMAP inhibitor that functions as a calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor. It blocks the interaction between SLMAP and CaMKII, thus affecting downstream signaling pathways involving CaMKII. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K-252a is a natural alkaloid isolated from the bacterium Nocardiopsis spp. It has been identified as an SLMAP inhibitor and can modulate the interaction between SLMAP and other proteins involved in cellular signaling. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
STO-609 is another CaMKII inhibitor that indirectly affects SLMAP by inhibiting CaMKII's activity. By targeting CaMKII, it can modulate SLMAP function. | ||||||
Flunarizine | 52468-60-7 | sc-337841 | 5 g | $560.00 | ||
Flunarizine is an antihistaminic and calcium channel blocker that has been reported to inhibit SLMAP function indirectly, possibly through its impact on calcium signaling pathways. | ||||||
Ethyl (4-trifluoromethylbenzoyl)acetate | 106263-53-0 | sc-228006 | 5 g | $395.00 | ||
This compound is a synthetic small molecule inhibitor that targets SLMAP function. Its exact mechanism of action may vary, and further research is needed to fully elucidate its mode of inhibition. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 is a calmodulin antagonist that indirectly inhibits the function of SLMAP by interfering with calmodulin-dependent signaling pathways. | ||||||
KN-92 | 1135280-28-2 | sc-311369 sc-311369A | 1 mg 5 mg | $186.00 $572.00 | 7 | |
KN-92 is a close structural analog of KN-93 and functions as a specific CaMKII inhibitor. By inhibiting CaMKII, it indirectly affects SLMAP-related processes. | ||||||
H-1152 dihydrochloride | 451462-58-1 | sc-203592 sc-203592A | 1 mg 5 mg | $104.00 $364.00 | 7 | |
H1152 is a selective inhibitor of Rho-associated protein kinase (ROCK), which can have downstream effects on SLMAP function through the RhoA signaling pathway. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a broad-spectrum protein kinase inhibitor that has been shown to inhibit CaMKII activity, thereby indirectly impacting SLMAP. | ||||||